Regulatory Approval Status: Manufactured under GMP conditions as a registered pharmaceutical intermediate/API; supplied with DMF and Certificate of Analysis support, not marketed as a standalone finished drug product
Indication: Anthelmintic effective against fascioliasis and paragonimiasis (liver/lung flukes) across camel, horse, cattle, goat, sheep, pig and poultry
Leave your rating & comment